Title Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Clinical Trial Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with.
The pace of change in practice-driving medical knowledge in new models of publishing May 5, 2013 Brian S. Alper, MD, MSPH, FAAFP Editor-in-Chief, DynaMed.
Oral Rivaroxaban for Symptomatic Venous Thrombroenbolism Group 9 611 - 10/06/11.
The pace of change in practice-driving medical knowledge in new models of publishing
